Shilpa Gampa, Regulatory Affairs Strategist, Freyr

Shilpa Gampa is a Regulatory affairs strategist with expertise in FDA submissions, SaMD (Software as a Medical Device) Regulatory compliance, and C-level executive consultation for developing go-to-market strategies. She is acting as the regional delivery head for America’s clients at Freyr in her primary role for global market submissions, with a focus on innovations and Regulatory strategies for medical devices and SaMD.